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ABSTRACT
The concentration levels of As in the Chilean II Region of Antofagasta produces non cancer health outcomes such as cardiovascular diseases and in last term 
heart attack. On this study, the determination of total As content and main inorganic and organoarsenic species found in three heart tissues (auricle, mammary 
artery and fat) and the saphene vein of people living in the Chilean II Region, suffering coronary thrombosis has been carried out. Comparison with similar tissues 
of patients from other non-contaminated areas has been undertaken.
The extraction of As species occurred in methanol: water (1:1) and As species determination have been used the tandem HPLC-ICP-MS using the Hamilton 
PRP X100 anion column. For total As determination has been performed by HG-AAS and ICP-MS.
The auricle and in less extend the saphene support the higher As concentration (mean values of 7.7 and 2.5 µg g-1, respectively), being As(III) the predominant 
species. Methylarsonate  (MA) and dimethylarsinate (DMA) is not a favoured mechanism. 
 The presence of high total As and high As(III) species content in the auricle and saphene of more contaminated people, the damage found in the saphene tissue 
and the global characteristics of the people under study in which the As stigmas are present in all of them, suggests that As could be involved in the cardiovascular 
diseases.
e-mail: ipizarro @uantof.cl
INTRODUCTION
The coastal – Andean Mountain – Upper Highlands Ecosystem of the II 
Region of Chile is an important area of the Atacama Desert; of which the River 
Loa basin is a part. This river is an aquatic desert ecosystem, and the source of 
drinking water for the cities in the II Region of Antofagasta in Chile. However, 
this particular ecosystem suffers from the chronic impact of endogenous 
arsenic due to volcanism in the area, and anthropogenic delivery of arsenic 
and other heavy metal due to mining activity 1,6, which transport trace elements 
more rapidly into ecosystem in comparison to the normal geological process, 
thus spreading the heavy metals to human beings, through the biogeochemical 
cycles 7.
It is worldwide known that  the  Chilean II Region has a heavy concentration 
of mining activity, related to the copper production and non metallic salts, 
producing more than two million tons of copper annually 8 and the well known 
“nitrato de Chile” from the potassium nitrate mines named “salitreras”. The 
Antofagasta city, in the west – centre of the Region, centralizes the social 
services and in it outskirts is located some industries related mining. So, the two 
principal sources of the As impact on the human  beings are the As associated 
to the mineral process which produces As contamination in the zone affecting 
people directly in some work places, and the As contamination problem 
from the main water supply. During the period 1950 – 1970, the medium As 
concentration in drinking water of Antofagasta was about 800 mg L-1 9. After 
installation of an As removal plants, the As concentration in drinking water 
dramatically decreased up to the recommended maximum level  of about 50 mg 
L-1, but fluctuations around this value gives a relatively high As content. In the 
Chiu-Chiu village without As removal plant, in 1998, drinking water contained 
750-800 mg L-1 of As at home 10, 11. At present, the World Health Organization12 
recommends a guidance value of 10 mg L-1. 
The chronic impact of As in the Region produces cancer and non cancer 
health outcomes 13. Cancer effects14 are in a similar way than in other well 
documented environmental As exposures of Taiwan15, India, Bangladesh, USA 
16, Mexico 17, Argentina and Hungary 18 -22; different type of cancer, mainly 
lung and bladder cancer have been reported as main problems As associated 
diseases. According Smith et al.23, the impact of As on the population mortality 
in the II Region of Chile is greater than that reported anywhere to date from 
environmental exposure to carcinogen in a major population; dose – response 
relation between As concentration in well water and mortality from cancers has 
been characterized 12, 24.
Typical clinical non cancer effects affecting the healthy life quality 
of the persons, associated with the inorganic As chronic ingestion through 
drinking water or environmental exposition have been studied and is reported 
in numerous papers. Vascular diseases, abnormal pigmentation, Raynand´s 
syndrome, acrocyanosis, hyperkeratosis, gangrene of fingers, ischemia of the 
tongue, diabetes, thrombosis, cerebral vascular disease, especially cerebral 
infarction,  coronary artery occlusions, and other cardiovascular diseases (CVD) 
has been associated with As exposure 10-12, 23-28. Less common complications 
such as liver enlargement (hepatomegaly), splenn enlargement (splenomegaly) 
and fluid in the abdomen (ascitis) also has been cited 29. 
Smoking, high serum low density lipoprotein cholesterol and high blood 
pressure have been shown to promote atherosclerotic disease in man. Yet these 
factors explain only about 60 per cent of the incidence of coronary heart disease 
(CHD) or CVD 30. Heart failure is not a uniform disease entity, but a syndrome 
with various causes, including hypertension, ischemia and congenital heart 
disease, cardiomyopathy, myocarditis and intoxication 31. As far as CVD are 
concerned, there is epidemiological evidence that trace elements may play 
a role 25, 32-35. However, the overall outcome of the cardiovascular disease 
epidemiological research has been to confirm the existence of water-related 
factors, independent of socio-economic or geographical influences on CVD. 
It has not been possible to identify a specific water constituent as responsible, 
and there is little hope of doing so by epidemiological research. Also, the 
nutritional evidence indicates that Cu is an antioxidant nutrient linked to an 
impressive array of biological mechanisms associated with CVD, however, 
most data arise from animal studies where induced copper deficiency was 
severe 36. Nevertheless, even more direct evidence respect the trace elements 
concern is necessary. Accordingly, recently it has been demonstrated that the 
effect of Ni on human cardiac tissue was related to oxidative stress 37. Appear 
not be apparent that the more direct evidence such as the speciated arsenic 
status in cardiovascular related tissues should be central to any discussion of 
trace elements and CVD.
The mechanism across mammalian animals including man metabolises and 
detoxify inorganic As is methylation to methylarsonate and dimethylarsinate 
38. Before this methylation arsenate must be reduced to arsenite; the binding 
of arsenite to tissue proteins would be an additional or perhaps the first 
step in the detoxification of inorganic As prior to methylation 39. Therefore, 
before methylation, increases the in vivo toxicity and risk to the organism 39. 
Otherwise, recently has been informed that biomethylation being a process that 
potentiates toxicity and carcinogenicity of inorganic As 40.
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In autopsy samples of people exposed to environmental basal  As levels, 
the concentration of the element is very similar in all internal organs (0.1 mg 
g-1) but slightly higher in hair (0.6 mg g-1) and nails ( 0.4 mg g-1). However 
after an acute lethal dose (8.0 g of As2O3), the highest levels were observed 
decreasing order in liver, kidney and other organs (muscle, lungs, brain). The 
inorganic trivalent species was predominant (>80%) and the metabolites MA 
and DMA represented 10 and 5% respectively except in lipid rich organs that 
concentrations of these species are higher 41. In animals arsenate has been 
shown to incorporate in the skeleton due to its similarity with phosphate 
anions. Background levels in breast milk range between 0.1 and 1 ng L-1, but 
concentrations multiplied by a factor of 4 have been observed in human in case 
of regular seafood consumption 42 and by a factor of 8 in case of consumption 
of drinking water containing 200 mg As L-1 43. Other data indicates that As can 
easily crosses the animal and human placentas 44.
The present study deals with the determination of total As content and 
main inorganic and organoarsenic species found in three heart tissues (auricle, 
mammary artery and fat) and the saphene vein (used as by-pass) of people 
chronically exposed to As in the Chilean II Region, suffering cardiovascular 
diseases (CVD) and subjected to heart surgery in Antofagasta. The found 
concentrations of total As and As species, and the histology study of some of 
these tissues, contribute to a best understanding about if As or its main species 
could be involved in the heart disease. 
EXPERIMENTAL
Instrumentation 
Hydride Generator equipped with an electrothermal mantle GBC EHG-
3000 and with an As hollow cathode boosted discharge lamp (BDL) from 
Photron was used to determine the total As content in the Chilean samples. 
The Inductively Coupled Plasma Mass Spectrometer (ICP-MS) used for 
the determination of total As concentrations in samples from persons living in 
Madrid, and as a detector after HPLC species separation, was an HP – 4500 
(Yokogawa Analytical System, Tokio, Japan).  This system was fitted with coof 
a Babington  glass  nebulizer  and a Scott double pass spray chamber. Single 
ion monitoring at m/z 75 was used to collect the data. All signal quantification 
was performed in the peak area mode.
A PRP-X100 analytical and guard anion-exchange column (Hamilton, 
Reno, NV, USA) were used for HPLC-ICP-MS analysis. The column effluent 
was directly introduced into the nebulizer via a 250 mm x 0.5 mm (id) 
polytetrafluoroethylene capillary tube. 
For chromatographic separations, a HPLC system (LDC Division, Riviera 
Beach, Florida, USA) was used as a sample pump. Air was removed from 
the buffers by argon degassing for 15 min and the buffer was filtered prior to 
injection. 100 µL of samples were introduced through a 0.45 µm nylon syringe 
filter into the injection valve Rheodyne 9125 (USA). 
TABLE 1 shows the optimized instrumental parameters for HG-AAS, ICP-
MS and HPLC system.
Reagents, Standards and Certified Reference Materials 
Sample mineralization were carried out in Teflon reactor bombs placed in 
usual lab oven and in heating aluminium plate by means a two steps procedure 
like similar way as Welz and Melcher 45. 
Solvent evaporation of extracts was performed in a Univapo100H-Unijet 
II system (UNIEQUIP, USA). Sonication of samples was performed in a 
focused ultrasonic bath  (Bandelin Sonopuls HD-2200, Fungilab S.A., USA). 
The extracting mixtures were prepared from deionised water (Milli-Q 
Ultrapure water systems, Millipore, USA) and HPLC-grade methanol (Merck, 
Darmstadt, Germany). High-purity nitric and hydrochloric acids were obtained 
by the sub-boiling distillation of the analytical-grade reagent (Merck) in an I.R. 
distiller (Berghof, BSB-939IR, Germany).
HF, HNO3 and H2SO4 acids were Suprapur grade (Merck); HClO4 and 
Na2S2O8 were Instra grade (J. T. Baker). Other reagents such as NaBH4, 
H2SO4, NaOH, (NH4)H2PO4, H3PO4, were obtained from Merck. Each 
arsenic species stock solution containing 1,000 g L-1 of As, was prepared by 
dissolving the respective amount of the pure compounds in water. As(III) 
and As(V) standards were prepared from  the sodium salt of arsenite and the 
sodium salt of arsenate  obtained from Sigma Aldrich (St Quintin, Fallavier, 
France) , DMA and  MA obtained from Merck, and arsenobetaine (AB) and 
arsenocholine (AC) obtained from Tri Chemical Laboratory Inc. (Japan). The 
stock solutions were kept at 4ºC in the dark. Working solutions were prepared 
daily and then diluted with water to the final concentration. Three certified 
from National Research Council Canada (NRCC) reference materials: Luts-1 
(non defatted Lobster hepatopancreas), Dorm-1 (Dogfish muscle) and Tort-1 
(Lobster hepatopancreas) were used to check the total As determination and 
also for As species characterisation.
Table 1: Instrumental parameters for total As determination and As 
speciation analysis.
Samples and sample pre treatment
Auricle tissue, saphene vein, mammary artery and heart fat tissues from 
about 200 patients operated in the Antofagasta Clinic of coronary thrombosis 
were analysed for total As content. The samples were obtained from a 
population under study, made up of patients who have lived at least five years 
in the II Region of Chile, and population control samples were obtained from 
patients operated in the Catholic University Clinic in Santiago of Chile, which 
coming from Chilean Regions without As problem.
All manipulations and procedures for the preparation of the samples 
were made in the bench of the “clean laboratory” inside a laminar flow hood 
(Labconco, Purifer Class II) using inert devices such as plastic and Titanium 
knives, agate grinding mortar, and scalpels, scissors and forceps of surgical 
stainless steel. In each case, then of be liberated of the Titanium clasp and the 
fats residues, the tissues were rinsed with deionised water and separated as 
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single samples, except the fat of which was prepared as pooled sample. All 
samples were stored at –20ºC before use. Dry weight / wet weight factors were 
obtained according UNEP protocol for biological tissues46.
From these samples, three different groups have been chosen for the study, 
results presentation and discussion:  Group I. More contaminated group formed 
by 20 people presenting the higher As content in the auricle (the tissue with 
higher mean As level).  Group II. Comparison group formed by 15 people 
presenting the lower As content in the auricle (probably the heart problem is 
not due to As); and Group III. Control group formed by 10 people suffering 
heart attack, which coming from V, VIII and IX Chilean Regions which are 
not exposed to the impact of arsenic (Valparaiso, Concepción and Temúco). 
Group IV. An additional samples from similar heart tissues were obtained for 
basal level from died persons living in Madrid where As contamination is not 
expected. Before operation, all the Chilean people initially analysed, filled in a 
survey with some personal characteristics for later relation with the As content. 
Table 2: Global characteristics of people under study.
Population Region Type of work Age (years)
As 
stigma
20
(high As 
content)
100%
Region II.
Mine: 55%
Industry: 40%
Others : 5%
57.2 (mean) 100% Yes
15
(low As 
content)
100%
Region II
Industry: 30%
Social: 70% 56.3 (mean) 100% No
10
(Control 
Group)
100%
(Valparaiso
Concepcion
Temúco)
V,VIII,IX 
Regions
Social: 60%
Agriculture: 
40%
66.0 (mean) 100%, No
Procedures
Mineralization for total arsenic  determination.
About 0.5 – 1.0 g of agate mortar grinded sample were placed in a Teflon 
reactor bomb45, 10 mL of concentrated  HNO3, 2 mL of concentrated HClO4 
and 2 mL of 2% m/v Na2S2O8 were added, and the sample was pre-digested 
overnight at room temperature. Next, the reactor was heated to 150ºC for 2 
hours in an oven. After cooling, 0.5 mL of concentrated H2SO4 was added 
and the digested sample was heated in the heating aluminium plate by semi 
refluxing in a 50 mL glass Erlenmeyer flask for about 2 hours (ambient to 300 
º C) until the final volume was about 2 mL. The digested sample was diluted 
to 10 mL with 0.5 M HCl and total As was determined by HG-AAS. When 
analysis was performed by ICP-MS, distilled water was used for making up to 
the chosen volumes. 
Extraction for As species.
About 0.5 –1.0 g of tissue materials were placed in plastic centrifuge 
tubes, and 10 mL of the methanol-water 1:1 v/v mixture was added following 
similar treatment that performed by Shibata and Morita 47. The mixture was 
mechanical shaken for 3 hours, maintained at 55ºC for 10 hours and finally left 
in an ultrasonic focalized bath for 5 min. The samples were centrifuged for 15 
min at 6000 rpm. After centrifugation, the extract was removed using a Pasteur 
pipette and the residue was re-extracted using 5 mL of the same methanol-
water mixture under the same operational conditions. The extraction procedure 
was repeated in the residue once again with a methanol – water mixture 9:1 
v/v following the procedure formerly described. The methanol – water 1:1 
and 9:1 extracts were separately submitted to rotary evaporator at 40ºC under 
reduced pressure and a flow of extra pure N2 . Each residue were dissolved in 
adequacy deionised filtered water volumes (0.45 mm), and kept frozen (-20ºC) 
prior analysis. Triplicates extracts were prepared from each one cardiovascular 
tissue sample from the patients in which the arsenic speciation was studied, and 
each one of the reference material LUTS-1, DORM-1 and Tort-1 for quality 
control measurements. The general procedure performed is summarized in 
FIGURE 1. 
Figure 1:  Procedure extraction for As species
Determination of total As.
Total As content from Chilean people was measured in the samples, 
extracts and residues (after methanol – water extractions) after mineralization 
by HG-AAS. The As content in the samples from Madrid (basal level), was 
measured by ICP-MS. Standard addition calibration was used for HG-AAS. 
External calibration using As(V) standard solution for ICP-MS was used. 72Ge 
was used as an internal standard for ICP-MS. 
HPLC – ICP – MS for As species
The extracts methanol-water 1:1 (two consecutive extractions) were 
diluted with diluted mobile phase solution depending species concentration. A 
PRP–X100 analytical coupled with a guard anion-exchange column (Hamilton, 
Reindeer, Nevada, USA) were used for HPLC–ICP–MS hyphenated analysis. 
For the HPLC chromatographic separations, 100 µL of samples were introduced 
through a 0.45-µm nylon syringe filter into the injection valve Rheodyne 9125 
(USA) and then pumped into the HPLC system (Milton Roy LDC Division, 
FL., USA); air was removed from the buffers by argon degassing for 15 min and 
the buffer filtered before injection. The column effluent was directly introduced 
into the nebulizer rod of the ICP–MS equipment by a polytetrafluoroethylene 
capillary tube of dimension 250 mm × 0.5 mm (id). The ion intensity at m/z 
of 75As was monitored, but an important interference during ICP–MS analysis 
is the possible formation of 40Ar35Cl, however chloride concentrations in the 
analyzed fractions were low and the eventual interference was corrected by 
the correction factor introduced in the operational software of the instrument. 
The chromatographic peaks were integrated using the software ICP–MS 
Plasma Lab and Captures Grams/32 (Galactic Industries Salem NY, USA). An 
injection of 100 µL of 5.0 ng/mL of 75As(V) was made, along with the internal 
standard (72Ge) before each chromatographic run in order to correct drift in the 
ICP–MS response. TABLE 1 shows the optimized instrumental parameters for 
the application of the ICP–MS and HPLC techniques.
Analytical validation and traceability of As measurements
TABLE 3 summarizes the analytic validation data to prove the suitability 
and efficiency of the described techniques for the determination of As in 
cardiovascular tissues; i.e. total As, total extracted As with methanol–water 
1:1 and 9:1 and the As recovery experiments from the standard reference 
materials spiked with As species frequently found in biological tissues, such as 
primary standard of As(III) and As (V) from   the sodium salt of  arsenite and 
the sodium salt of  arsenate; DMA; MA; AB and AC. The SRMs used in these 
quality control approaches were DORM-1, TORT-1 and LUTS-1. Detection 
limits were calculated in accordance with IUPAC criteria 48,49. The results of 
the measured values of arsenic were accepted if the coefficient variation of 
the precision and accuracy tests were less to 15 % of the accepted or certified 
values, respectively.
Before being applied to the cardiovascular tissue samples, the As speciation 
protocol was applied to samples of standard reference materials (TABLE 3). 
These results are very similar to those in other reports 50 - 53 .
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Table 3: Quality control and traceability of the total As concentrations, MeOH–H2O 1:1 fractionated As concentrations and species concentrations of As using 
standard reference materials (SRM).
Total As by 
HGAAS
Total As found in                                    
                                                                                                                                                      
MeOH-H2O 1:1  extract
by HGAAS
N
5
5
5
5
5
5
SRM
DORM-1
LUTS-1
TORT-1
DORM-1
LUTS-1
TORT-1
Average found 
concentration
(µg/g)
17.2
3.00
22,1
16.7 
2.35 
21.7 
Certified concentration 
(µg/g)
17,7
2,83
24,6
17.7                                                                         
2.83
24.6
RE (%)
-3.1
4.6
-3.8
4.9
5.0
6.4
RSD (± %)
7.9
2.8
7.0
5.8
6.3
5.1
CL (ng/mL)
0.69
0.14
0.56
0.09
0.07
0.05
Spiked arsenic species measurements in MeOH-H2O 1:1 SRM extracts by HPLC – ICPMS
SRM N As Species Species found(µg /g)
RSD (± 
%) Species spiking
Species recovery 
(%)
CL
(ng / mL)
TORT – 1 3
As3+
As5+
MA
DMA
AB
Nd
0.33
Nd
2.04
17.0
-
0.09
-
0.9
1.7
50 ng/mL
98.6
96.5
96.9
98.3
95.1
0.02
0.03
0.06
0.05
0.03
LUTS – 1 3
As3+
As5+
MA
DMA
AB
Nd
Nd
Nd
0.15
1.81
-
-
-
0.07
0.6
50 ng/mL
97.2
95.7
96.5
98.5
95.3
0.02
0.03
0.06
0.05
0.03
DORM – 1 3
As3+
As5+
MA
DMA
AB
Nd
Nd
Nd
0.66
15.1
-
-
-
0.09
0.8
50 ng/mL
96.6
95.4
96.9
98.9
95.1
0.02
0.03
0.06
0.05
0.03
Histological treatment 
For the histological study performed in some samples, the tissue was 
washed for 24 hours in running water and fixed in paraffin blocks dyed with 
hematoxilin-eosine, trichromic of Masson and orceine Van Giesson 54. The 
histochemical methods its based on combination of chromogenic reagents with 
mixtures of masking agents that block the reactivity of tissues. The paraffinzed 
sections show green granules, insoluble in water, through dissolved by acid 
and by ammonium hydroxide. This procedure demonstrates pretty well every 
practical histopathologic with additional diagnostic studies such as histological 
examination in microscopic scission.
RESULTS AND DISCUSSION
Total As content
The interval and mean value for total As found in the samples of the four 
analysed groups are given in TABLE 4. In the Group I (more contaminated), 
the auricle has by far the higher concentration, with a mean value of 7.7 mg 
g-1, dry tissue, following by the saphene vein with 2.5 mg g-1. Mamalian artery 
and fat tissues in this group, present similar but lower As concentration than 
the former tissues with about 1 mg g-1 each. The total As concentrations found 
in the auricle (and also saphene) of some people, not chosen as components of 
the Group I, are really high of about 20 mg g-1 that reveal the high impact of 
the As in some individuals living and working in the contaminated areas. The 
comparison (TABLE 4) between Group II (less As contaminated in the Region) 
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and Group III, (people from V, VIII an IX Chilean Regions), shows that concentration in the different tissues are quite similar. Considering the long distance 
between both population groups, these values can be considered as the mean level in these tissues for Chilean people.
Table 4: Concentration intervals and mean value for total As in the analysed tissues for the different analysed groups.
              N                                         3                                        3                                          3                                        3
Tissue Group I.(mg g
-1)
(high As content) 
Group II.(mg g-1)
 (low As content)
GroupII. (mg g-1)
(control group)
Group IV.(ng  g-1)
(basal group)
Auricle  7.44 – 9.47.70 ±3.85
0.79 – 1.22
1.0±0.54
0.5 – 1.2
0.90±0.27 32.0 ± 2.0 
Saphene vein 1.1 – 7.72.50±1.64
0.26 – 1.8
0.90±0.29
0.56 – 1.6
1.0±0.45
(ventricule)
44.0 ± 3.0 
Mammary artery 1.49 – 2.181.10±0.39
0.12 – 1.7
0.60±0,25
0.32 – 1.2
0.8±0.19
Fat 0.40 – 3.11.0 ± 0.32
0.37 – 1.6
1.70±0,43
0.47 – 1.5
0.80± 0.32
However they are quite high comparing the basal level of the whole heart 
tissue of about 0.003 – 0.026 µg g-1 55 dry tissue and the Group IV of a person 
living in Madrid. 
Histological study
FIGURES 2 and 3 shows the histological plates for the saphene of a 
damaged and non-damaged tissue  respectively. The vascular pathology, 
FIGURE 2, is type concentric intimal fibrosis. This vein-damage consists in the 
expansion of the internal surface due to miofibroblastos and due to this expand, 
the light circumference is strongly reduced. In this case, the tissue is seriously 
ill and the intimal layer has analogous thickness than the muscular layer. The 
concentric intimal fibrosis does not belong to the principal atherosclerotic 
disease damage, main causes for heart attack and is produced by age, or by the 
influence of chemical or immunological processes. In our case, the person is 
relatively  young (45 years old) and  can be suspected of As as the main cause 
of the tissue damage. Then, appear not to be apparent that arsenic may cause 
necrosis in cardiovascular tissues of the man 32. However, at the light of the 
new knowledge, a critical issue is how to distinguish between apoptosis and 
necrosis 33. The total As concentration found in the saphene of this patient was 
of 2.1 mg g-1. 
Figure 2: Histological study of a saphene vain suffering concentric a 
intimal fibrosis.
Figure 3: Histological study of a normal saphene vein.
As species  found in the different analysed tissues.
Six species were considered for As speciation in the tissues. As(III) 
and As(V) because they are the main contaminant species. MA and DMA 
because both are the main products of the cellular biomethylation through the 
conjugated effects of S-adenosylmethionine and the methyltransferase enzyme. 
Arsenobetaine (AB) and  arsenocholine (AC) because they can enter the human 
organism through food, mainly of marine origin. 
The four tissues (auricle, saphene, mammary artery and fat) of some 
people from the Group I has been analysed for As species. 
TABLE 5 contains the total As concentration, extraction efficiency on 
methanol-water 1:1 (two consecutive extractions), and methanol water 9:1 
(after the two first extractions) in the above cellular residue, and % of non 
extracted As retained in the cellular residual material.
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Table 5: Fractionation of total As concentration (µg g-1 dry weight) in cardiovascular tissues expressed in extraction efficiency (%) on methanol-water 1:1, 
and methanol water 9:1 (see text) and % of non extracted As on the residue. Nd = no detected.
N Auricle 3 Mammary artery 3 Saphenous vein 3 Fat tissue 3
Total As (µg/g) 6.9 ±2.1 0.9 ± 0.2 4.96 ± 1.2 0.8 ± 0.2
Fractionation and chromatographic arsenic speciation. 
MeOH–H2O (1:1)                                  Extraction efficiency (%)
Total As 
As3+
As5+
MA
DMA
AB
70.9 ± 3.1
42.4 ± 2.3
6.8 ± 1.5
Nd
Nd
Nd
60.3 ± 2.7
Nd
29.8 ± 2.6
3.8 ± 0.9
6,2 ± 1.9
18.8 ± 2.4
56.2 ± 2.9
30.1 ± 3.2
4.4 ± 1.2
Nd
3.1 ± 1.5
Nd
67.4 ± 2.9
Nd
21.5 ± 2.5
Nd
5.8 ± 1.9
33.9 ± 2.9
MeOH–H2O (9:1) 
Total As 19.3 ± 2.0
Extraction efficiency (%)
26.2 ± 2.5 29.7 ± 2.9 30.3 ± 2.2
Residual As % 9.1 ± 1.8 12.0 ± 1.1 12.2 ±1.3 1.9 ± 0.7
TABLE 5 shows the results of the As fractionation in methanol–water 
mixtures 47 and the IC–HPLC–MS chromatographic speciation of the 
cardiovascular tissues. These results show that most of the As in the tissues 
examined was extracted by the 1:1 and 9:1 methanol–water-extracting 
solutions; this has also been observed in other biological tissues47. Under these 
conditions, the As species contained in these cells could be extracted and the 
As speciation investigated. Most of the total As concentrations were extracted 
in 1:1 methanol–water-extracting solution, so we can assume that at least the 
1:1 methanol–water extract contains the As species of the cytosol solution.
FIGURES 4 (a-e) shows the chromatograms of the species of mixture of 
As species containing 15 mg L-1 of AB and 5mg L-1 of the other As species 
and As species content in the methanol-water extract of a person of Group I, 
and the after one  methanol water 1:1 extraction. FIGURES 5 (a-d), shows the 
percentage of each of the present species of this person. Similar chromatograms 
and species were obtained for other people in this group (not shown).
(a) Standard of As species 
containing 15mg L-1 of AB and 
5mgL-1of the others As species
(b) Auricle
Figure 4: Chromatograms for As species, after methanol-water 1:1 
extraction.
Figure 5: Percentage of As extraction and As species referred to dry 
tissue for: (a) auricle, (b) saphene, (c) fat and (d) mammary artery tissues after 
methanol-water 1:1 extraction.
First of all it is important to point out that most of the As present in all 
the tissues is extracted in the methanol-water 1:1 extract, TABLE 5. Methanol-
water 9:1 extract coming from the cellular residues resulted be the preferred 
medium for organoarsenic compounds, but more works are in progress to this 
respect. 
From FIGURES (4b and 5a), can be seen that in the case of auricle, only 
As(III) and As(V) are the species present in the tissue. After the first methanolic 
extraction which contain to the cytosol solution, the As(III) extracted was 
about 50% of the total As content in the tissue. The As(V) is about 10% of 
the total. This result is interesting because As(V) is the main contaminant 
species present in the natural waters, therefore biotranformation to As(III) 
is a main mechanism. Not other species seems to be present. Both inorganic 
As species were confirmed by spiking with standard solutions of the species. 
Completely symmetrical increases of the peaks were obtained. As(III) was also 
characterised using the cationic column Hamilton PRP X200 (Mobile phase 
4mM pyridine/formiate, pH 2.8  mode isocratic,chromatograms not given) in 
which As(III) is not overlapped with other possible species.
In the saphene vein also As(III) and As(V) are the main species present, 
but little amount of other species such as DMA was found. One again the 
As(III) is the predominant species in the methanolic extract, which could 
involve that free As(III) specie is a principal component of the cytosol solution 
in this cardiovascular tissues.
In fat tissue AB is the predominant species and in the mammary artery the 
As(V) species, that account about 40% and 30% respectively of the total As 
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content in the respective tissues. Both As species were confirmed by spiking 
with standard solutions of the species. Completely symmetrical increases of 
the peaks were obtained. AB was also characterised using the cationic column 
Hamilton PRP X200 (Mobile phase 4mM pyridine/formiate, pH 2.8 mode 
isocratic, chromatograms not given) in which AB is not overlapped with other 
possible species. The arsenic species stability was also monitored during 
sample preparation and storage 56. 
Dorm-1 and Tort-1 species have also been quantified and although only 
total As is certified in both materials, our species concentration are close to 
the reported in others works 50-53. Our results were in mg g-1, for Dorm-1: AB 
(15.0), and DMA (0.54), and the reported paper from others50-53 are AB (15.5 
-14.1) and DMA (0.60). For the Tort-1 material, we found AB (15.3), DMA 
(1.41) and As(V) (0.30) and AC (Nd), and the reported results were: AB (16.0) 
, DMA (1.64, and 1.01), AC ( 0.04), and As(V) (0.39) 57 - 59. 
CONCLUSIONS
It is known that inorganic As species have a high affinity for proteins 
containing conjugated sulphur groups and therefore extracellular and 
intracellular proteins could bind As. Although inorganic As(III) is the main 
species bounded to proteins, some other studies report, for example, that 
in the rat liver intracellular solution, about  one half of the methylated As 
species were protein bound 60. Treatments such as precipitation of proteins 
with 5% trichloroacetic acid, thiol – reactive agents (ex. N-ethylmaleimide, 
b-mercaptoethanol)  or chelators ( ex. 2,3 dimercaptopropanol) failed to release 
most protein-bound to arsenicals. Treatment with CuCl releases about 90% 
of all protein-bound arsenicals 61. The fact that the methanol – water 1:1 and 
9:1 extracting solutions yield higher than 80% of As species in most of the 
biological samples and also in the heart tissues analysed in this work, suggest 
that intracellular As species can be extracted in these extracting mixtures. 
Transporters as carrier proteins, channels and ion pumps have all been 
regarded as mechanisms that are capable of permitting the movement of ions 
across the cell membranes by both electrochemical gradient and the different 
composition of intracellular and extra cellular fluids 62.
One surprising fact is that the DMA and MA species are absent in the 
auricle tissue and the concentration of DMA is very low in the saphene vein 
in Group I, mostly considering that these species are the main species formed 
in the detoxification mechanism. Some explanation can be highlighted: i) the 
lack of methylation mechanisms because of the lack of methylating agents in 
these tissues; ii) at a certain inorganic As dose level, the methylation efficiency 
decreases in animals and humans 61; iii) the incapability of DMA to bind some 
cell constituents as in the case of lungs of rabbits has been found 63,64.
The presence of high total As and high As(III) species content in the 
auricle and saphene of more contaminated people (Group I), the damage found 
in the saphene tissue and the global characteristics of the people under study 
in which the As stigmas are present in all of them, suggests that As could be 
involved in the cardiovascular diseases (CVD). 
Additional studies to know the association between As species and 
proteins are now in progress.
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